RedHill Biopharma (RDHL) Change in Account Payables: 2016-2022
Historic Change in Account Payables for RedHill Biopharma (RDHL) over the last 6 years, with Dec 2022 value amounting to -$554,000.
- RedHill Biopharma's Change in Account Payables rose 84.53% to -$554,000 in Q4 2022 from the same period last year, while for Dec 2022 it was -$7.4 million, marking a year-over-year decrease of 6797.30%. This contributed to the annual value of -$2.1 million for FY2024, which is 121.64% down from last year.
- Latest data reveals that RedHill Biopharma reported Change in Account Payables of -$554,000 as of Q4 2022, which was down 234.79% from $411,000 recorded in Q3 2022.
- RedHill Biopharma's 5-year Change in Account Payables high stood at $6.8 million for Q2 2021, and its period low was -$6.0 million during Q1 2022.
- For the 3-year period, RedHill Biopharma's Change in Account Payables averaged around -$448,909, with its median value being -$554,000 (2022).
- In the last 5 years, RedHill Biopharma's Change in Account Payables tumbled by 5,235.90% in 2018 and then surged by 2,372.55% in 2020.
- Quarterly analysis of 5 years shows RedHill Biopharma's Change in Account Payables stood at -$543,000 in 2018, then dropped by 12.34% to -$610,000 in 2019, then skyrocketed by 448.03% to $2.1 million in 2020, then tumbled by 268.68% to -$3.6 million in 2021, then skyrocketed by 84.53% to -$554,000 in 2022.
- Its last three reported values are -$554,000 in Q4 2022, $411,000 for Q3 2022, and -$1.3 million during Q2 2022.